8 Munich healthtech investors back biotech and digital health startups in 2026. MIG Fonds backed BioNTech from Munich. Boehringer Ingelheim and Roche Venture Fund provide direct pharma and diagnostics deployment access. Munich's LMU Klinikum is Europe's largest hospital for clinical pilot programs.
Munich is Germany's healthcare capital with LMU Klinikum treating 500K+ patients annually. LMU Klinikum and TU Munich Klinikum rechts der Isar are Europe's top clinical AI research hospitals.
Bavaria committed €600M to life sciences through its Biotech Cluster strategy 2025-2030. Munich's Martinsried biotech park houses 100+ life sciences companies - Europe's most dense biotech cluster.
Roche Diagnostics Munich and Siemens Healthineers run active healthtech pilot programs. Roche Diagnostics Munich has 5,000+ employees and processes 1B+ diagnostic tests annually.
This guide covers 8 active healthtech investors in Munich writing cheques in 2026.
| Type | Check size | Sector focus | Website | |
|---|---|---|---|---|
| MIG Fonds | Life sciences growth fund | $2M-$20M | Biotech, medtech, digital health, AI health | mig-fonds.de |
| Bayern Kapital | State seed fund | $300K-$3M | Healthtech, life sciences, medtech | bayernkapital.de |
| HV Capital | Growth VC | $3M-$30M | Digital health SaaS, health consumer tech | hvcapital.com |
| Munich Re Ventures | Health insurance CVC | $2M-$20M | Digital health, health insurance tech, risk data | munichre.com/ventures |
| UnternehmerTUM Ventures | University VC | $500K-$5M | Healthtech spinouts, medtech, diagnostics | unternehmertum.de |
| Boehringer Ingelheim Venture Fund | Pharma CVC | $2M-$15M | Biotech, drug discovery, AI therapeutics | boehringer-ingelheim.com |
| Roche Venture Fund | Diagnostics CVC | $2M-$15M | Diagnostics AI, digital pathology, medtech | roche.com |
| Earlybird Venture Capital | Multi-stage VC | $1M-$20M | Digital health, health SaaS, medtech | earlybird.com |
Ellty shows who reviewed your clinical data and regulatory documentation. Follow up at the right moment.
Start free 14-day trialMunich healthtech VCs require clinical validation data from LMU or TU Munich Klinikum. Founders with a named Munich hospital pilot close Munich healthtech rounds 5 months faster.
MDR Class IIa compliance documentation is the first technical question from Munich medtech VCs. Munich medtech founders with CE marking timeline and Notified Body selected close Series A faster.
Organize your clinical data and regulatory documentation in a data room that tracks which VCs reviewed your clinical evidence and MDR sections. Munich healthtech VCs do extensive regulatory diligence - know who reviewed yours first.
GKV (statutory health insurance) reimbursement pathway is the key commercial question. DiGA certification from BfArM or GKV pilot letter converts Munich digital health VCs to term sheets.
Munich healthtech founders who close fastest have LMU Klinikum clinical data, MDR classification confirmed, and a DiGA application in progress. Clinical credibility plus regulatory roadmap - that combination closes Munich rounds.
Munich's dedicated pharma and healthtech fund with LMU and Max Planck network.
Recent Deals: Pharma and healthtech investments 2025; LMU and Max Planck connections; Munich clinical network
LinkedIn: MIG Fonds LinkedIn
Sector Focus: Healthtech, pharma, biotech
Stage Focus: Seed, Series A
Location: Munich, Germany
Website: mig-fonds.de
Bavaria's public healthtech seed with DiGA-ready co-investment and LMU connections.
Recent Deals: Healthtech seed co-investments 2025-2026; Bavaria public matching; DiGA-ready company support
LinkedIn: Bayern Kapital LinkedIn
Sector Focus: Healthtech, digital health
Stage Focus: Pre-seed, seed
Location: Landshut, Germany
Website: bayernkapital.de
Germany's largest VC for healthtech with German payer and hospital network connections.
Recent Deals: Healthtech investments 2025; largest German VC by AUM; German payer and hospital connections
LinkedIn: HV Capital LinkedIn
Sector Focus: Healthtech, digital health, B2B
Stage Focus: Seed to Series B
Location: Munich, Germany
Website: hv.capital
Munich Re's CVC with health insurance and reinsurance distribution mandate.
Recent Deals: Healthtech and insurtech investments 2025-2026; Munich Re health insurance network; reinsurance data
LinkedIn: Munich Re Ventures LinkedIn
Sector Focus: Healthtech, insurtech, health insurance
Stage Focus: Seed to growth
Location: Munich, Germany
Website: munichre.com
TU Munich venture arm with Klinikum Munich and LMU clinical trial network.
Recent Deals: Healthtech investments 2025; Klinikum Munich and LMU clinical connections; DiGA pathway support
LinkedIn: UnternehmerTUM Ventures LinkedIn
Sector Focus: Healthtech, deep tech, digital health
Stage Focus: Seed, Series A
Location: Munich, Germany
Website: unternehmertum.de
Pharma CVC with global Boehringer Ingelheim clinical and research network.
Recent Deals: Pharma and biotech investments 2025-2026; Boehringer Ingelheim clinical network; global pharma access
LinkedIn: Boehringer Ingelheim Venture Fund LinkedIn
Sector Focus: Healthtech, pharma, biotech
Stage Focus: Seed to growth
Location: Ingelheim, Germany
Website: boehringer-ingelheim-venture.com
Ellty shows you which healthtech VCs opened your deck and how long they spent on it.
Start free 14-day trialRoche's CVC for digital health and diagnostics with global Roche lab network.
Recent Deals: Digital health and diagnostics investments 2025-2026; Roche global lab network; diagnostics mandate
LinkedIn: Roche Venture Fund LinkedIn
Sector Focus: Healthtech, diagnostics, digital health
Stage Focus: Seed to growth
Location: Basel, Switzerland
Website: roche.com
European healthtech pioneer with DiGA regulatory expertise and Munich hospital network.
Recent Deals: Healthtech investments 2025-2026; Earlybird Edition Feb 2026; DiGA pathway and Munich hospital network
LinkedIn: Earlybird Venture Capital LinkedIn
Sector Focus: Healthtech, digital health, DiGA
Stage Focus: Seed to Series B
Location: Berlin, Germany
Website: earlybird.com
DiGA certification makes digital therapeutics reimbursable by all 90+ German statutory insurers. DiGA-certified apps reach 75M+ GKV-insured patients without individual insurer negotiation.
BfArM DiGA fast-track approval takes 3 months - the fastest digital health reimbursement in the EU. Munich digital health founders who apply for DiGA before Series A close Munich VC rounds 30% faster.
Track your DiGA application and VC fundraising with cap table management tools that manage regulatory milestones and investor equity terms simultaneously. Munich healthtech VCs check DiGA status before any term sheet discussion.
DiGA annual evaluation requires real-world evidence data from 3,000+ GKV patients. Munich healthtech founders should launch DiGA pilots at seed - evidence collection takes 12+ months.
LMU Klinikum is Germany's largest university hospital with 50+ dedicated clinical research units. LMU clinical trial partnerships close Munich healthtech VC rounds 4 months faster than solo academic trials.
German Clinical Trials Register (DRKS) requires registration before any human subject trial. DRKS registration is free and converts Munich healthtech VCs - it signals regulatory maturity.
Track your Munich clinical trial partnerships with investor relations tools that log VC engagement alongside hospital collaboration milestones. Munich healthtech VCs verify LMU affiliation before any investment committee discussion.
Bavaria's DFG-funded clinical study network connects Munich startups to 80+ clinical study centers. DFG multi-center study approval converts Munich biotech VCs from exploratory to term sheet in weeks.
Munich healthtech rounds close 25% slower than Berlin but average 40% larger cheques. Munich VCs run deeper clinical diligence but back larger initial investments for strong clinical data.
Berlin healthtech favors digital health SaaS. Munich backs biotech and hardware medtech. Munich's Martinsried cluster and LMU hospital network are unique advantages Berlin cannot replicate.
Review our term sheet guide before negotiating with Munich healthtech VCs. German healthtech term sheets include clinical milestone gates and MDR warranty clauses.
Munich-Berlin dual-track is the standard path for German digital health scale-ups at Series B. Raise Munich Series A with clinical anchor, then add Berlin-based growth VC for Series B scale.
Venture Capital in 2026: AI, Liquidity & Startup Funding Explained
Lead with LMU clinical validation and MDR classification. Clinical data converts Munich VCs.
Ellty is a data room for healthtech founders. Track which VCs engage with your clinical docs.


